With these previous findings in glioblastoma, colon carcinoma, gastric cancer, cholangiocarcinoma, and ovarian cancer, our data also found that high expression of apelin was significantly associated with invasion and metastatic features and poor prognosis in patients with muscle-invasive bladder cancer. Here, APLN is linked to cholangiocarcinoma.